Trademark: CASEBIA THERAPEUTICS 1905684
Word
CASEBIA THERAPEUTICS
ID
1905684
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
16 January 2018
Registration Date
16 January 2018
Renewal Date
25 July 2027
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 5:
Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders